Korea United Pharm Inc. (KRX: 033270)

Korea United Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Other Revenue	-0	-0	0	-	-	-
Revenue	161,437	155,190	136,891	134,830	145,453	134,979
Revenue Growth (YoY)	8.00%	13.37%	1.53%	-7.30%	7.76%	13.35%
Cost of Revenue	76,635	74,201	67,228	62,393	59,465	52,887
Gross Profit	84,802	80,988	69,663	72,437	85,988	82,091
Selling, General & Admin	55,658	52,683	49,532	49,243	54,494	57,280
Research & Development	4,155	3,989	3,005	1,299	1,272	1,530
Other Operating Expenses	837.72	830.55	919.87	766.86	784.89	709.16
Operating Expenses	61,006	58,501	54,826	52,927	58,959	62,011
Operating Income	23,796	22,487	14,837	19,510	27,029	20,080
Interest Expense	-778.31	-1,015	-982.57	-911.63	-1,438	-1,307
Interest & Investment Income	840.76	639	1,014	949.2	504.99	361.01
Earnings From Equity Investments	-987.95	-50.63	-111.46	-327.29	80.79	369.19
Currency Exchange Gain (Loss)	1,506	523.45	-140.23	-296.74	80.56	-267.46
Other Non Operating Income (Expenses)	56.69	231.54	1,033	2,287	-3,417	-438.6
EBT Excluding Unusual Items	24,433	22,815	15,649	21,211	22,840	18,798
Gain (Loss) on Sale of Investments	1,216	-2.37	-69.54	-1	-35.82	-
Gain (Loss) on Sale of Assets	-31.08	-33.23	-10.93	-648.15	-79.32	806.11
Pretax Income	25,618	22,780	15,569	20,562	22,725	19,604
Income Tax Expense	5,548	4,300	3,365	4,191	2,528	2,544
Earnings From Continuing Operations	20,070	18,479	12,204	16,370	20,197	17,060
Minority Interest in Earnings	-48.97	-104.49	8.17	8.41	10.65	-4.06
Net Income	20,021	18,375	12,212	16,379	20,208	17,056
Net Income to Common	20,021	18,375	12,212	16,379	20,208	17,056
Net Income Growth	20.99%	50.46%	-25.44%	-18.95%	18.48%	20.11%
Shares Outstanding (Basic)	16	16	16	15	14	15
Shares Outstanding (Diluted)	16	16	16	15	15	15
Shares Change (YoY)	-2.69%	-0.66%	5.22%	3.94%	-3.14%	-2.25%
EPS (Basic)	1260.90	1163.44	775.00	1081.00	1398.04	1148.04
EPS (Diluted)	1260.76	1160.00	766.00	1081.00	1386.27	1133.33
EPS Growth	24.32%	51.44%	-29.14%	-22.02%	22.32%	22.85%
Free Cash Flow	10,987	13,265	6,863	-6,649	12,666	3,801
Free Cash Flow Per Share	691.96	837.53	430.47	-438.86	868.90	252.54
Dividend Per Share	200.000	200.000	-	-	-	-
Gross Margin	52.53%	52.19%	50.89%	53.72%	59.12%	60.82%
Operating Margin	14.74%	14.49%	10.84%	14.47%	18.58%	14.88%
Profit Margin	12.40%	11.84%	8.92%	12.15%	13.89%	12.64%
Free Cash Flow Margin	6.81%	8.55%	5.01%	-4.93%	8.71%	2.82%
EBITDA	30,474	29,639	21,012	23,859	31,345	24,381
EBITDA Margin	18.88%	19.10%	15.35%	17.70%	21.55%	18.06%
D&A For EBITDA	6,678	7,152	6,175	4,348	4,316	4,301
EBIT	23,796	22,487	14,837	19,510	27,029	20,080
EBIT Margin	14.74%	14.49%	10.84%	14.47%	18.58%	14.88%
Effective Tax Rate	21.66%	18.88%	21.61%	20.38%	11.12%	12.98%
Advertising Expenses	-	4,530	4,287	4,475	5,481	6,922

Source: S&P Capital IQ. Standard template. Financial Sources.